|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.87 CNY | +1.19% |
|
+6.13% | -18.32% |
| 05-25 | Mayinglong Pharmaceutical Gets Regulatory Approval for Eye Drops | MT |
| 04-24 | Mayinglong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 9.86B 1.46B 1.28B 1.17B 1.09B 2.07B 139B 2.1B 14.07B 5.47B 68.21B 5.47B 5.35B 235B | P/E 2026 * |
14.7x | P/E 2027 * | 12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 9.86B 1.46B 1.28B 1.17B 1.09B 2.07B 139B 2.1B 14.07B 5.47B 68.21B 5.47B 5.35B 235B | EV / Sales 2026 * |
2.28x | EV / Sales 2027 * | 2.07x |
| Free-Float |
64.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.19% | ||
| 1 week | +4.00% | ||
| Current month | +5.78% | ||
| 1 month | -5.96% | ||
| 3 months | -11.01% | ||
| 6 months | -18.32% | ||
| Current year | -18.32% |
| 1 week | 21.22 |  | 23 |
| 1 month | 21.22 | | 24.3 |
| Current year | 21.22 | | 29.22 |
| 1 year | 21.22 | | 30.18 |
| 3 years | 20.2 | | 31.46 |
| 5 years | 17.99 | | 33.34 |
| 10 years | 12.52 | | 33.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
You Zhang Xia
CEO | Chief Executive Officer | 48 | 2019-05-27 |
Tao Mao
DFI | Director of Finance/CFO | 49 | 2023-12-27 |
Ping An Liu
PRN | Corporate Officer/Principal | 40 | 2021-08-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Ping Chen
CHM | Chairman | 64 | 2010-03-15 |
You Zhang Xia
BRD | Director/Board Member | 48 | 2019-05-27 |
Yue Zhou
BRD | Director/Board Member | 40 | 2022-06-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.19% | +4.00% | -17.70% | -17.76% | 1.43B | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.85% | +31.30% | +24.86% | 339B | |
| -0.56% | +2.80% | +39.13% | +28.20% | 301B | |
| -0.08% | +1.52% | +29.96% | +42.13% | 292B | |
| -1.54% | +3.56% | -25.96% | -40.53% | 225B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +2.00% | +4.70% | +26.17% | +49.18% | 370.12B | |
| Weighted average by Cap. | +2.24% | +5.54% | +41.69% | +81.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.32B 638M 559M 513M 479M 907M 60.72B 919M 6.16B 2.4B 29.88B 2.39B 2.34B 103B | 4.75B 702M 615M 565M 527M 999M 66.85B 1.01B 6.79B 2.64B 32.89B 2.64B 2.58B 113B |
| Net income | 674M 99.55M 87.21M 80.08M 74.7M 142M 9.48B 143M 962M 374M 4.66B 374M 366M 16.06B | 745M 110M 96.39M 88.51M 82.57M 157M 10.48B 159M 1.06B 413M 5.15B 413M 404M 17.75B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | CN¥22.87 | +1.19% | 4,168,745 |
| 26-07-02 | CN¥22.60 | +1.62% | 4,969,360 |
| 26-07-01 | CN¥22.24 | +2.87% | 4,920,490 |
| 26-06-30 | CN¥21.62 | -2.92% | 4,886,673 |
| 26-06-29 | CN¥22.27 | +3.34% | 6,254,597 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600993 Stock
Select your edition
All financial news and data tailored to specific country editions
